The selective dopamine D3 receptor antagonist SB-277011-A attenuates ethanol consumption in ethanol preferring (P) and non-preferring (NP) rats

Pharmacology Biochemistry and Behavior

Volumn 81, Issue 1, 2005, Pages 190-197

  Thanos, Panayotis K ^a,e   Katana, John M ^a   Ashby Jr , Charles R ^b   Michaelides, Michael ^a   Gardner, Eliot L ^c   Heidbreder, Christian A ^d   Volkow, Nora D ^a,e  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b ST JOHN'S UNIVERSITY   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^d GSK   (Italy)

^e NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Addiction; Alcoholism; Dopamine; Drinking

Indexed keywords

ALCOHOL; DOPAMINE 3 RECEPTOR; DOPAMINE 3 RECEPTOR BLOCKING AGENT; N [4 [2 (6 CYANO 1,2,3,4 TETRAHYDROISOQUINOLIN 2 YL)ETHYL]CYCLOHEXYL] 4 QUINOLININECARBOXAMIDE; SB 277011 A; UNCLASSIFIED DRUG;

ALCOHOL CONSUMPTION; ALCOHOLISM; ANIMAL EXPERIMENT; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; LICKING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT;

ALCOHOL DRINKING; ANIMALS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHANOL; MALE; NITRILES; RATS; RATS, WISTAR; SPECIES SPECIFICITY; TETRAHYDROISOQUINOLINES;

EID: 19344375941     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2005.03.013     Document Type: Article

References (35)

1. M. Andreoli, M. Tessari, M. Pilla, E. Valerio, J.J. Hagan, and C.A. Heidbreder Selective antagonism at dopamine D(3) receptors prevents nicotine-triggered relapse to nicotine-seeking behavior Neuropsychopharmacology 28 2003 1272
2. C.R. Ashby Jr., Y. Minabe, G. Stemp, J.J. Hagan, and D.N. Middlemiss Acute and chronic administration of the selective D(3) receptor antagonist SB-277011-A alters activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study J Pharmacol Exp Ther 294 2000 1166 1174
3. C.R. Ashby Jr., M. Paul, E.L. Gardner, C.A. Heidbreder, and J.J. Hagan Acute administration of the selective D3 receptor antagonist SB-277011A blocks the acquisition and expression of the conditioned place preference response to heroin in male rats Synapse 48 2003 154 156
4. K. Blum, E.P. Noble, P.J. Sheridan, A. Montgomery, T. Ritchie, and P. Jagadeeswaran Allelic association of human dopamine D2 receptor gene in alcoholism JAMA 263 1990 2055 2060
5. K. Blum, J.C. Cull, E.R. Braverman, and D.E. Commings Reward deficiency syndrome Am Sci 84 1996 132 145
6. K. Blum, E.R. Braverman, J.M. Holder, J.F. Lubar, V.J. Monastra, and D. Miller Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors J Psychoactive Drugs 32 Suppl: i-iv 2000 1 112
7. J.M. Boyce, and F.O. Risinger Dopamine D3 receptor antagonist effects on the motivational effects of ethanol Alcohol 28 2002 47 55
8. J.M. Boyce-Rustay, and F.O. Risinger Dopamine D3 receptor knockout mice and the motivational effects of ethanol Pharmacol Biochem Behav 75 2003 373 379
9. P. Di Ciano, R.J. Underwood, J.J. Hagan, and B.J. Everitt Attenuation of cue-controlled cocaine-seeking by a selective D3 dopamine receptor antagonist SB-277011-A Neuropsychopharmacology 28 2003 329 338
10. A.M. Gonzalez, and D.R. Sibley [3H]7-OH-DPAT is capable of labeling dopamine D2 as well as D3 receptors Eur J Pharmacol 272 1995 R1 R3
11. B.F. Grant, T.C. Harford, D.A. Dawson, P. Chou, M. Dufour, and R. Pickering Prevalence of DSN-IV alcohol abuse and dependance: United States, 1992 Alcohol Health Res World 18 1994 243 246
12. Guide for the Care and Use of Laboratory Animals National academy of sciences, national research council, commission on life sciences, institute of laboratory animal resources 1996 National Academy Press Washington, DC
13. I. Gyertyan, and K. Gal Dopamine D3 receptor ligands show place conditioning effect but do not influence cocaine-induced place preference NeuroReport 14 2003 93 98
14. H. Harwood The economic costs of drug abuse in the US 1998 National Institute on alcohol abuse in the U.S Washington, D.C.
15. H. Harwood The economic costs of alcohol in the U.S. 2000 National Institute on Alcohol Abuse and Alcoholism Washington, D.C.
16. C.A. Heidbreder, M. Andreoli, C. Marcon, P. Thanos, C.R. Ashby Jr., and E.L. Gardner Role of dopamine D3 receptors in the addictive properties of ethanol Drugs Today 40 4 2004 355 365
17. B. Le Foll, J.C. Schwartz, and P. Sokoloff Disruption of nicotine conditioning by dopamine D(3) receptor ligands Mol Psychiatry 8 2003 225 230
18. L. Lumeng, and T. Hawkins New strains of rats with alcohol preference and non preference Alcohol Aldehyde Metab Syst 3 1977 537 544
19. L. Lumeng, M.B. Waller, W.J. McBride, and T.K. Li Different sensitivities to ethanol in alcohol-preferring and -nonpreferring rats Pharmacol Biochem Behav 16 1982 125 130
20. W.J. McBride, and T.K. Li Animal models of alcoholism: neurobiology of high alcohol-drinking behavior in rodents Crit Rev Neurobiol 12 1998 339 369
21. W.J. McBride, E. Chernet, R.N. Russell, D.T. Wong, X.-M. Guan, and L. Lumeng Regional CNS densities of monoamine receptors in alcohol-naive alcohol-preferring P and -nonpreferring NP rats Alcohol 14 1997 141 147
22. M. Narita, M. Soma, H. Tamaki, and T. Suzuki Intensification of the development of ethanol dependence in mice lacking dopamine D(3) receptor Neurosci Lett 324 2002 129 132
23. T.J. Phillips, R. Hen, and J.C. Crabbe Complications associated with genetic background effects in research using knockout mice Psychopharmacology (Berl) 147 1999 5 7
24. C. Reavill, S.G. Taylor, M.D. Wood, T. Ashmeade, N.E. Austin, and K.Y. Avenell Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-A J Pharmacol Exp Ther 294 2000 1154 1165
25. P. Sokoloff, B. Giros, M.P. Martres, M.L. Bouthenet, and J.C. Schwartz Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics Nature 347 1990 146 151
26. M. Suzuki D3 dopamine receptor upregulation reduces cocaine self-administration Brain Res 779 1998 58 74
27. P.K. Thanos, N.D. Volkow, P. Freimuth, H. Umegaki, H. Ikari, and G. Roth Overexpression of dopamine D2 receptors reduces alcohol self-administration J Neurochem 78 2001 1094 1103
28. Thanos PK, Rivera SN, Weaver K, Grandy DK, Rubinstein M, Umegaki H, et al. Dopamine D2R DNA Transfer in dopamine D2 receptor-deficient mice: effects on ethanol drinking. Life Sci in Press.
29. P.K. Thanos, N. Taintor, S.N. Rivera, H. Umegaki, H. Ikari, and G. Roth DRD2 gene transfer into the nucleus accumbens of the alcohol preferring (P) and non preferring (NP) rats attenuates alcohol drinking Alcohol Clin Exp Res 28 2004 720 728
30. N.D. Volkow, J.S. Fowler, G.J. Wang, R. Hitzemann, J. Logan, and D.J. Schlyer Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers Synapse 14 1993 169 177
31. N.D. Volkow, G.-J. Wang, J.S. Fowler, J. Logan, R. Hitzemann, and Y.-S. Ding Decreases in dopamine receptors but not in dopamine transporters in alcoholics Alcohol Clin Exp Res 20 1996 1594 1598
32. N.D. Volkow, G.-J. Wang, J.S. Fowler, P. Thanos, J. Logan, and S.J. Gatley D2 receptors predict reinforcing effects of stimulants in humans: replication study Synapse 46 2002 79 82
33. S.R. Vorel, C.R. Ashby Jr, M. Paul, X. Liu, R. Hayes, and J.J. Hagan Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats J Neurosci 22 2002 9595 9603
34. N. Waters, L. Lofberg, S. Haadsma-Svensson, K. Svensson, C. Sonesson, and A. Carlsson Differential effects of dopamine D2 and D3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behaviour J Neural Transm Gen Sect 98 1994 39 55
35. M. Xu, T.E. Koeltzow, G.T. Santiago, R. Moratalla, D.C. Cooper, and X.T. Hu Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors Neuron 19 1997 837 848